Argent BioPharma Limited
$6.00-7.69%($-0.50)
TickerSpark Score
41/100
40
Valuation
60
Profitability
55
Growth
20
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RGT.L research report →
52-Week Range20% of range
Low $0.22
Current $6.00
High $29.60
Company
- CEO
- Roby Reuven Zomer
Price Chart
-70.73% · this period
Valuation
- Market Cap
- $4.18M
- P/E
- 0.00
- P/S
- 5.53
- P/B
- 0.00
- EV/EBITDA
- -0.62
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 76.50%
- Op Margin
- -2646.84%
- Net Margin
- -3058.43%
- ROE
- 258.94%
- ROIC
- 4766.67%
Growth & Income
- Revenue
- $891.08K · -73.70%
- Net Income
- $-17,531,000 · 15.81%
- EPS
- $-0.47 · 93.39%
- Op Income
- $-16,700,000
- FCF YoY
- -18.20%
Performance & Tape
- 52W High
- $29.60
- 52W Low
- $0.22
- 50D MA
- $12.67
- 200D MA
- $17.67
- Beta
- 1.08
- Avg Volume
- 14.31K
Get TickerSpark's AI analysis on RGT.L
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our RGT.L Coverage
We haven't published any research on RGT.L yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RGT.L Report →